Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 88Colonic Neoplasms 30Colonic Polyps 20Adenoma 11Colorectal Neoplasms, Hereditary Nonpolyposis 6Disease 5Rectal Neoplasms 4Polyps 4Neoplasms 4Gastrointestinal Neoplasms 4Stomach Neoplasms 2Peptic Ulcer 2Pancreatic Neoplasms 2Liver Cirrhosis 2Intestinal Neoplasms 2Intestinal Diseases 2Gastritis, Atrophic 2Digestive System Diseases 2Anus Neoplasms 2Adenomatous Polyps 2Adenomatous Polyposis Coli 2Turcot syndrome 1Tuberculosis 1Triple Negative Breast Neoplasms 1Recurrence 1Rectal Diseases 1Patient Satisfaction 1Pancreatitis, Chronic 1Obesity 1Non-alcoholic Fatty Liver Disease 1

Interventions

pembrolizumab 1Sutures 1Surgical Instruments 1Specimen Handling 1Ringer's Lactate 1Proctocolectomy, Restorative 1Proctectomy 1Nivolumab 1Lysine Acetyltransferase 5 1Loperamide 1Laparoscopy 1Hydroxyethyl Starch Derivatives 1Endoscopy 1Educational Status 1Colonoscopy 1CVD protocol 1Biopsy 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colitis, Ulcerative × Colonoscopy × Gastrointestinal × Clear all
NCT04767984 2026-01-21

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Northwestern University

Phase 2 Active not recruiting
42 enrolled
Gastrointestinal

Colitis, Ulcerative, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡